publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,If participants failed to return outcome questionnaires they were telephoned once to remind them.,fulltext,If participants failed to return outcome questionnaires they were telephoned once to remind them.,100.0
1528,PRECIS-2,"The main analysis evaluated the total costs of the intervention, resource use and medication at eight months after randomization, but costs at four months follow-up were also recorded.",fulltext,"The main analysis evaluated the total costs of the intervention, resource use and medication at eight months after randomization, but costs at four months follow-up were also recorded.",100.0
1528,PRECIS-2,"Those who were not able to complete the outcome measures, such as people with visual problems, were visited by a researcher who was unaware of their group allocation, who completed the questionnaires with them.",fulltext,"Those who were not able to complete the outcome measures, such as people with visual problems, were visited by a researcher who was unaware of their group allocation, who completed the questionnaires with them.",100.0
1528,PRECIS-2,"Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12, 7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, 8 thus confirming they had low mood.",100.0
1528,PRECIS-2,The EQ-5D was included as a generic quality of life measure.,fulltext,The EQ-5D 9 was included as a generic quality of life measure.,100.0
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,PRECIS-2,"In the intervention group, there was an overall reduction in resource use from baseline to eight months follow-up of £30,985 (mean per patient reduction of £429).",fulltext,"In the intervention group, there was an overall reduction in resource use from baseline to eight months follow-up of £30,985 (mean per patient reduction of £429).",100.0
1528,PRECIS-2,"To ascertain costs, a questionnaire was used to assess the use of NHS services and prescribed medication in the previous three months.",fulltext,"To ascertain costs, a questionnaire was used to assess the use of NHS services and prescribed medication in the previous three months.",100.0
1528,PRECIS-2,"Clusters of eight participants, who could attend groups on the same day, were randomly allocated, using a web-based randomization programme prepared in advance by the Clinical Trials Unit at Nottingham University, to an intervention or control group.",fulltext,"Clusters of eight participants, who could attend groups on the same day, were randomly allocated, using a web-based randomization programme prepared in advance by the Clinical Trials Unit at Nottingham University, to an intervention or control group.",100.0
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1529,PRECIS-2,"To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.",fulltext,"To investigate depression, anxiety, and stress, DASS-21, developed by Lovibond and Lovibond in 1995, was used and its validity and reliability were confirmed [17]. To measure fatigue, the Piper Standard Scale was used.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session). The technique of increasing intimacy as the most important source of happiness–the technique of giving priority to happiness and making it invaluable (the sixth session); the technique of expressing emotions, the technique of enhancing optimism (the seventh session); reviewing all the techniques taught, administering post-test (the eighth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135 131 fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session). The technique of increasing intimacy as the most important source of happiness–the technique of giving priority to happiness and making it invaluable (the sixth session); the technique of expressing emotions, the technique of enhancing optimism (the seventh session); reviewing all the techniques taught, administering post-test (the eighth session).",100.0
1529,PRECIS-2,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",fulltext,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",100.0
1529,PRECIS-2,"Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",fulltext,"Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",100.0
1529,PRECIS-2,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants. Accordingly, 70 numbers, equal to the number of people required in each group, were developed and the numbers 1e70 were randomly assigned to two groups: experimental and control. After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.",fulltext,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants. Accordingly, 70 numbers, equal to the number of people required in each group, were developed and the numbers 1e70 were randomly assigned to two groups: experimental and control. After eligible patients referred to the Association, a number was randomly assigned to each patient according to his/her referring time and the patients were assigned to the two groups.",100.0
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1567,PRECIS-2,"The 70-min battery included the following widely used tests: the Controlled Oral Word Association Test (COWAT) - verbal fluency and word finding; The California Verbal Learning Test, 2nd ed, (CVLT-II) - verbal learning and remembering; The Brief Visuospatial Memory Test e Revised (BVMT-R) - nonverbal learning and memory; The Paced Auditory Serial Addition Test (PASAT) - auditory information processing speed and flexibility, as well as calculation abilities; and The Symbol Digit Modalities Test (SDMT) - complex scanning and visual tracking.",fulltext,"The 70-min battery included the following widely used tests: the Controlled Oral Word Association Test (COWAT) 26 - verbal fluency and word finding; The California Verbal Learning Test, 2nd ed, (CVLT-II) 27 - verbal learning and remembering; The Brief Visuospatial Memory Test e Revised (BVMT-R) 28 nonverbal learning and memory; The Paced Auditory Serial Addition Test (PASAT) 29 - auditory information processing speed and flexibility, as well as calculation abilities; and The Symbol Digit Modalities Test (SDMT) 30 - complex scanning and visual tracking.",99.81651376146789
1567,PRECIS-2,"For the current study, we employed intention-to-treat strategies to handle missing data using a “last observation carried forward” (LOCF) strategy in which missing data points are imputed based on the participant's existing data.",fulltext,"For the current study, we employed intention-to-treat strategies to handle missing data using a “last observation carried forward” (LOCF) strategy in which missing data points are imputed based on the participant's existing data.",100.0
1567,PRECIS-2,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the 8-week MAPPS intervention, and 3 and 6 months post-intervention.",fulltext,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",93.08510638297872
1567,PRECIS-2,"18e60 years of age, able to understand and comply with the study protocol, visual acuity with correction sufficient to work on a computer screen, clinically definite MS for at least 6 months and exacerbation free for 90 days",fulltext,"18e60 years of age, able to understand and comply with the study protocol, visual acuity with correction sufficient to work on a computer screen, clinically definite MS for at least 6 months and exacerbation free for 90 days",100.0
1567,PRECIS-2,Computer-assisted cognitive rehabilitation in persons with multiple sclerosis: Results of a multi-site randomized controlled trial with six month follow-up,fulltext,Computer-assisted cognitive rehabilitation in persons with multiple sclerosis: Results of a multi-site randomized controlled trial with six month follow-up,100.0
1567,PRECIS-2,"The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",fulltext,"The primary purpose of this study was to determine the effectiveness of a novel computerassisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",99.57983193277312
1567,PRECIS-2,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy.",fulltext,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy.",100.0
1567,PRECIS-2,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"score ≥ 10 [on the Perceived Deficits Questionnaire], indicating some problems in at least 5 areas",fulltext," The Perceived Deficits Questionnaire 19 was administered by phone, and those scoring at least 10 (indicating some problems in at least 5 areas",85.71428571428572
1567,PRECIS-2,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving). The games/tasks (see Table 1) were arranged so that the most basic cognitive skills (attention) were addressed first.",fulltext,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving). The games/tasks (see Table 1) were arranged so that the most basic cognitive skills (attention) were addressed first.",100.0
1567,PRECIS-2,"Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",fulltext,"Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas.",100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles",100.0
1568,PRECIS-2,Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment.,fulltext,Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment.,100.0
1568,PRECIS-2,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",fulltext,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",100.0
1568,PRECIS-2,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,"Therefore, the exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",fulltext,"Therefore, the exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks.",100.0
1568,PRECIS-2,Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax.,fulltext,Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax.,100.0
1568,PRECIS-2,Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES),fulltext,Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES),100.0
1568,PRECIS-2,In addition to usual care the control group of this study received four 1.5-hour health educational sessions throughout the study periods of 48 weeks.,fulltext,In addition to usual care the control group of this study received four 1.5-hour health educational He,68.0
1568,PRECIS-2,The present study is a national multicentre single-blinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,fulltext,The present study is a national multicentre singleblinded parallel group randomized controlled trial (RCT) comparing two groups receiving either supervised exercise therapy (intervention group) or health education (active control group).,99.57983193277312
1569,PRECIS-2,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5. This criteria reflects the inclusion of PwMS with an unassisted but limited walking competency (100–500 m).",fulltext,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5. This criteria reflects the inclusion of PwMS with an unassisted but limited walking competency (100–500 m).",100.0
1569,PRECIS-2,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance.,fulltext,The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance.,100.0
1569,PRECIS-2,"TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step). PwMS exercised for 5 min in each one (3 min of activities and 2 min of rest). A full description of exercise protocol is available elsewhere. They underwent two laps during each session that take about 60 min (6 workstations x 5 min x 2 laps), with 10 min of rest after each lap.",fulltext," TOCT includes six workstations with five levels of complexity (step, slalom, tandem exercise, goals, obstacles, long step). PwMS exercised for 5 min in each one (3 min of activities and 2 min of rest). A full description of exercise protocol is available elsewhere (Straudi et al., 2014). They were encouraged to increase their level of functioning among sessions. They underwent two laps during each session that take about 60 min (6 workstations x 5 min x 2 laps), with 10 min of rest after each lap",99.75186104218362
1569,PRECIS-2,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,100.0
1569,PRECIS-2,An intention-to-treat analysis was carried out on all outcome measures,fulltext,An intention-to-treat analysis was carried out on all outcome measures,100.0
1569,PRECIS-2,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation. They signed informed consent before any evaluation or treatment.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation. They signed informed consent before any evaluation or treatment.,100.0
1569,PRECIS-2,"The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.",fulltext," The blind evaluator, who did not supervise the training program, performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program",99.6078431372549
1569,PRECIS-2,1569.pdf,prompt,2015.pdf,75.0
1570,PRECIS-2,"Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of β-interferon under the supervision of a neurologist in a period of no more than 30 days prior to the study.",fulltext,"iteria: Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI according to McDonald’s criteria, acceptance of the 24 month protocol by the patients, not being pregnant or lactating, history of having received a kind of βinterferon under the supervision of a neurologist in a period of no more than 30 days prior to t",97.26775956284153
1570,PRECIS-2,"30 patients received Av (30 mcg IM on a weekly basis), 30 patients received Re (44 mcg SC three times a week) and 30 patients received Be (250 mcg SC on an alternate day basis).",fulltext,"30 patients received Av (30 mcg IM on a weekly basis), 30 patients received Re (44 mcg SC three times a week) and 30 patients received Be (250 mcg SC on an alternate day basis).",100.0
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2",95.0920245398773
1570,PRECIS-2,At the onset of treatment all of the patients had an EDSS of less than 6.,fulltext,At the onset of treatment all of the patients had an EDSS of less than 6.,100.0
1570,PRECIS-2,1570.pdf,prompt,2015.pdf,75.0
1570,PRECIS-2,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated",fulltext,"At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated",100.0
1570,PRECIS-2,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",fulltext,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",100.0
1769,PRECIS-2,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",100.0
1769,PRECIS-2,The dose of corticotrophin was adjusted to produce just enough,fulltext,The dose of corticotrophin was adjusted to produce just enough,100.0
1769,PRECIS-2,"There is no evidence to suggest that the treated group do better than the controls, either from the point of view of deterioration or reduction in number or severity of relapses.",fulltext,"There is no evidence to suggest that the treated group do better than the controls, either from the point of view of deterioration or reduction in number or severity of relapses.",100.0
1769,PRECIS-2,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",fulltext,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",100.0
1769,PRECIS-2,A separate trial was carried out in the three centres using the same treatment and scoring methods. Patients with multiple sclerosis were randomly selected into treated and control groups;,fulltext, separate trial was carried out in the three centres using the same treatment and scoring methods. Patients with multiple sclerosis were randomly selected into treated and control groups;,99.46808510638297
1769,PRECIS-2,of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,fulltext,of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,100.0
1769,PRECIS-2,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,fulltext,Patients with diabetes mellitus or hypertension or who gave a history of psychiatric illness or peptic ulcer were not admitted to the treated group.,100.0
1769,PRECIS-2,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,100.0
1769,PRECIS-2,"This controlled study was started in 1963 in three cities-Belfast, Leeds, and Manchester.",fulltext,"This controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester.",98.87640449438202
1769,PRECIS-2,1769.pdf,prompt,2015.pdf,62.5
1769,PRECIS-2,mooning,fulltext,mooning,100.0
1770,PRECIS-2,Only patients with a clinical or laboratory supported definite diagnosis of MS according to the Poser criteria were included.,fulltext,"ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",62.4
1770,PRECIS-2,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",fulltext,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",100.0
1770,PRECIS-2,At entry the exacerbation had been lasting less than 8 weeks and no spontaneous recovery had occurred.,fulltext,At entry the exacerbation had been lasting less than 8 weeks and no spontaneous recovery had occurred.,100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,PRECIS-2,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",fulltext,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",100.0
1770,PRECIS-2,1770.pdf,prompt,2015.pdf,62.5
1770,PRECIS-2,"In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed.",fulltext,"In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed.",100.0
1770,PRECIS-2,"Assessment included: EDSS, FS, AI, ISS, in the 6th and 12th week an overall impression by both the patient and the neurologist in a 7-point scale (from much worse via unchanged to much better), and on a 3-point scale (worse, unchanged, better) in the 6th, 9th and 12th month.",fulltext,"Assessment included: EDSS, FS, AI, ISS, in the 6th and 12th week an overall impression by both the patient and the neurologist in a 14 7-point scale (from much worse via unchanged to much better), and on a 3-point scale (worse, unchanged, better) in the 6th, 9th and 12th month.",100.0
1771,PRECIS-2,Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N),fulltext,Assessments included the Brief Repeatable Battery of Neuropsychological tests (BRB-N),100.0
1771,PRECIS-2,"For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al.23",fulltext,"For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see LangeskovChristensen et al. ",98.0
1771,PRECIS-2,"For inclusion and exclusion criteria, see Langeskov-Christensen et al24",fulltext,"For inclusion and exclusion criteria, see LangeskovChristensen et al. ",95.77464788732395
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",100.0
1771,PRECIS-2,"At inclusion, a neurologist examined participants to determine the Expanded Disability Status Scale (EDSS) score, unless a recent score (<6 months) followed by a disease stable period existed.",fulltext,"At inclusion, a neurologist examined participants to determine the Expanded Disability Status Scale (EDSS) score, unless a recent score (<6 months) followed by a disease stable period existed.",100.0
1771,PRECIS-2,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test).",fulltext,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO 2 -max test).",100.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",100.0
1771,PRECIS-2,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HRmax).",fulltext,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity M Langeskov-Christensen, LG Hvid et al. journals.sagepub.com/home/msj 3 increased from 65% to 95% of individual maximum heart rate (HR max ",99.4186046511628
1772,PRECIS-2,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",fulltext,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",100.0
1772,PRECIS-2,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.",fulltext,"a Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) Calkwood et al. BMC Neurology 2014, 14:220 Page 2 of 11 http://www.biomedcentral.com/1471-2377/14/220 score of 0–5.5 were eligible to participate in the stud",99.08256880733946
1772,PRECIS-2,All outcomes were evaluated after 6 months of treatment.,fulltext,All outcomes were evaluated after 6 months of treatment.,100.0
1772,PRECIS-2,Patients were required to have been naïve to fingolimod treatment.,fulltext,. Patients were required to have been naïve to fingolimod treatmen,96.96969696969697
1772,PRECIS-2,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15,98.70967741935483
1772,PRECIS-2,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,fulltext,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,100.0
1772,PRECIS-2,Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial,fulltext,Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial,100.0
1772,PRECIS-2,"This was measured using the Global Satisfaction subscale score on the TSQM v1.4, where higher scores indicate greater satisfaction.",fulltext,"This was measured using the Global Satisfaction subscale score on the TSQM v1.4, where higher scores indicate greater satisfaction.",100.0
1773,PRECIS-2,"To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.",fulltext,"To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time.",100.0
1773,PRECIS-2,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",fulltext,"Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",100.0
1773,PRECIS-2,None of the patients had previous experience with resistance training.,fulltext,None of the patients had previous experience with resistance training.,100.0
1773,PRECIS-2,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,PRECIS-2,Subjects were requested to push with maximal effort during the concentric phase of the movement (90–180°) and to lower the load (eccentric action; 180–90°) in a controlled manner.,fulltext,Subjects were requested to push with maximal effort during the concentric phase of the movement (90–180 ◦ ) and to lower the load (eccentric action; 180–90 ◦ ) in a controlled manner.,100.0
1773,PRECIS-2,"Patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",fulltext,"ing to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",66.29213483146069
1773,PRECIS-2,1773.pdf,prompt,2015.pdf,62.5
1773,PRECIS-2,"Data were analyzed using SPSS® 17.0 (SPSS Inc., USA).",fulltext,"Data were analyzed using SPSS ® 17.0 (SPSS Inc., USA).",100.0
1773,PRECIS-2,Table 2 shows the progressive loading scheme used during the resistance training program.,fulltext, the sessions included in the resistance training program.,58.42696629213483
1773,PRECIS-2,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, average power and muscle endurance.",fulltext,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, aver",75.78125
1773,PRECIS-2,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
1773,PRECIS-2,Subjects performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period (Table 2). Recovery time between sets was 3 minutes.,fulltext,ts performed 3 sets of 8–12 reps with a load that was progressively increased from 35 to 70% of MVIC through the training period (Table 2). Recovery time between sets was 3 minutes.,96.79144385026738
1773,PRECIS-2,All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,fulltext,All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain).,99.11504424778761
648,PRECIS-2,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",fulltext,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery.",100.0
648,PRECIS-2,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit.",fulltext,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit.",99.41520467836258
648,PRECIS-2,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",fulltext,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",100.0
648,PRECIS-2,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,fulltext,All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon.,100.0
648,PRECIS-2,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",fulltext,"CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",100.0
648,PRECIS-2,Women were analysed in the groups into which they were allocated.,fulltext,Women were analysed in the groups into which they were allocated.,100.0
650,PRECIS-2,Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.,fulltext,Patients with a clinically established diagnosis of type 2 diabetes mellitus were sent a letter by their GPs to introduce the SMS project.,100.0
650,PRECIS-2,"During the training sessions, PNs started to integrate SMS into their routine care practice.",fulltext," the training sessions, PNs started to integrate SMS into their routine care practice.",93.47826086956522
650,PRECIS-2,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.,fulltext,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study.,100.0
650,PRECIS-2,"In 10% of the sample, one follow-up measurement was missing. Three patients did not complete the baseline measurement and gave informed consent at the 4-month follow-up measurement. Another 23 patients completed only the baseline measurement.",fulltext,". In 10% of the sample, one follow-up measurement was missing. Three patients did not complete the baseline measurement and gave informed consent at the 4-month follow-up measurement. Another 23 patients completed only the baseline measuremen",99.17355371900827
650,PRECIS-2,Analyses were performed on an intention-to-treat basis.,fulltext,Analyses were performed on an intention-to-treat basis.,100.0
650,PRECIS-2,Both problem solving and reattribution techniques were intended to result in action plans indicating how patients would achieve their personal goals.,fulltext,Both problem solving and reattribution techniques were intended to result in action plans indicating how patients would achieve their personal goals.,100.0
650,PRECIS-2,The study was conducted between November 2011 and February 2013 and was registered in a Dutch public trial registry [NTR2764]. The study protocol has been published elsewhere.,fulltext,The study was conducted between November 2011 and February 2013 and was registered in a Dutch public trial registry [NTR2764]. The study protocol has been published elsewhere.,100.0
650,PRECIS-2,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",fulltext,"PNs supported patients in the processes of defining problems and finding solutions themselves, by applying problem-solving and reattribution techniques.",100.0
650,PRECIS-2,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,PRECIS-2,"SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",fulltext,"SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",100.0
650,PRECIS-2,Only 16 of the 117 patients in the intervention arm (14%) who were found eligible by the posted research-driven screening questionnaire were detected by their practice nurses.,fulltext,Only 16 of the 117 patients in the intervention arm (14%) who were found eligible by the posted research-driven screening questionnaire were detected by their practice nurses.,100.0
650,PRECIS-2,"The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice. It included the ‘Daily Functioning Thermometer’ (DFT), which is a Visual Analogue Scale to measure how suffering under the burden of diabetes affects patients’ perceived functioning in everyday life.",fulltext,"The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice. It included the ‘Daily Functioning Thermometer’ (DFT), which is a Visual Analogue Scale to measure how suffering under the burden of diabetes affects patients’ perceived functioning in everyday life.",100.0
650,PRECIS-2,650.pdf,prompt,015.pdf,71.42857142857143
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
650,PRECIS-2,PNs in the intervention arm were trained to integrate SMS into their routine consultations.,fulltext,s in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,97.8021978021978
650,PRECIS-2,"From all 1805 patients who participated in the screening, 357 (20%) met the detection criteria and were invited to take part in the trial.",fulltext,". From all 1805 patients who participated in the screening, 357 (20%) met the detection criteria and were invited to take part in the tria",98.55072463768117
650,PRECIS-2,The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.,fulltext,The enclosed self-administered questionnaire consisted of the screening instruments that intervention PNs would also apply for SMS in their routine practice.,100.0
651,PRECIS-2,"After the screening visit (week –2) and baseline visit (week 0), study assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",fulltext,"After the screening visit (week –2) and baseline visit (week 0), study assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",100.0
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,"In the first-line controller therapy trial, eligible patients had asthma symptoms deemed by their physician to require initiation of asthma-controller therapy.",fulltext,"In the first-line controller therapy trial, eligible patients had asthma symptoms deemed by their physician to require initiation of asthma-controller therapy.",100.0
651,PRECIS-2,The primary outcome measure was the MiniAQLQ score.,fulltext,The primary outcome measure was the MiniAQLQ score.,100.0
651,PRECIS-2,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",fulltext,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",100.0
651,PRECIS-2,"Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",fulltext,"Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",100.0
651,PRECIS-2,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,fulltext,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,100.0
651,PRECIS-2,Patients who withdrew from the study continued to receive care from their usual clinician.,fulltext,Patients who withdrew from the study continued to receive care from their usual clinician.,100.0
651,PRECIS-2,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,PRECIS-2,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",100.0
651,PRECIS-2,Main exclusion criteria were prior treatment within 12 weeks with an inhaled glucocorticoid or LTRA (in the first-line controller therapy trial) or LTRA or LABA (in the add-on therapy trial).,fulltext,Main exclusion criteria were prior treatment within 12 weeks with an inhaled glucocorticoid or LTRA (in the first-line controller therapy trial) or LTRA or LABA (in the add-on therapy trial).,100.0
651,PRECIS-2,Patients who met the eligibility criteria completed a validated asthma-symptom diary for 2 weeks before the baseline visit for an assessment of PEF variability and to record current symptoms.,fulltext,Patients who met the eligibility criteria completed a validated asthma-symptom diary 28 for 2 weeks before the baseline visit for an assessment of PEF variability and to record current symptoms.,100.0
655,PRECIS-2,"Secondly, additional analyses were conducted using linear mixed models, adjusted for baseline values and including time-group interaction terms.",fulltext,"Secondly, additional analyses were conducted using linear mixed models, adjusted for baseline values and including time-group interaction terms.",100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session ",100.0
655,PRECIS-2,The hospital-based outpatient programme consisted of three training sessions a week which included 30 min of weight lifting and 30 min of leg cycle ergometry along with four educational sessions which included chest physiotherapy training.,fulltext,The hospital-based outpatient programme consisted of three training sessions a week which included 30 min of weight lifting J.B. Galdiz et al. / Arch Bronconeumol. 2021;57(3):195–204 197 and 30 min of leg cycle ergometry along with four educational sessions which included chest physiotherapy training ,100.0
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months.",100.0
655,PRECIS-2,"The study was carried out in accordance with the principles of the Declaration of Helsinki and started after receiving authorization from the Spanish Agency for Medicines and Health Products and the approval of the Basque Country Ethics Committee, as well as the local Ethics Committee and Director at each institution. All patients gave written informed consent.",fulltext,"The study was carried out in accordance with the principles of the Declaration of Helsinki and started after receiving authorization from the Spanish Agency for Medicines and Health Products and the approval of the Basque Country Ethics Committee, as well as the local Ethics Committee and Director at each institution. All patients gave written informed consent.",100.0
655,PRECIS-2,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",100.0
655,PRECIS-2,"The study was carried out in accordance with the principles of the Declaration of Helsinki and started after receiving authorization from the Spanish Agency for Medicines and Health Products and the approval of the Basque Country Ethics Committee, as well as the local Ethics Committee and Director at each institution.",fulltext,"The study was carried out in accordance with the principles of the Declaration of Helsinki and started after receiving authorization from the Spanish Agency for Medicines and Health Products and the approval of the Basque Country Ethics Committee, as well as the local Ethics Committee and Director at each institution.",100.0
655,PRECIS-2,Health-related quality of life (HRQoL) was measured using a generic instrument (SF-36) and the Chronic Respiratory Disease Questionnaire (CRQ).,fulltext,Health-related quality of life (HRQoL) was measured using a generic instrument (SF-36) 12 and the Chronic Respiratory Disease Questionnaire (CRQ).,100.0
655,PRECIS-2,"At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",100.0
655,PRECIS-2,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6-min walk test (6MWT).,fulltext,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT. ,85.71428571428572
655,PRECIS-2,Missing values were not imputed. All patients were analyzed in the group to which they were randomized.,fulltext,Missing values were not imputed. All patients were analyzed in the group to which they were randomized.,100.0
655,PRECIS-2,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines and having been clinically stable for the previous 4 weeks.",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines 9 and having been clinically stable for the previous 4 weeks ",100.0
657,PRECIS-2,"Inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",fulltext,"inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria 27 ; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",100.0
657,PRECIS-2,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
657,PRECIS-2,"To ensure maximum patient enrollment, 1 reminder letter was sent out to the nonresponders.",fulltext,"To ensure maximum patient enrollment, 1 reminder letter was sent out to the nonresponders.",100.0
657,PRECIS-2,The participants were allowed to use a walking aid if preferred and were encouraged to use the same walking aid and shoes for all assessments.,fulltext,The participants were allowed to use a walking aid if preferred and were encouraged to use the same walking aid and shoes for all assessments.,100.0
657,PRECIS-2,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual’s impairments underlying his or her balance disturbance. The physical therapists individualized the exercises by tailoring them according to each individual’s symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",fulltext,"The physical therapists conducted an individual clinical examination of each participant. The examinations were followed by group sessions, in which the physical therapists chose from 33 exercises, all with 5 levels of difficulty to address each individual’s impairments underlying his or her balance disturbance. The physical therapists individualized the exercises by tailoring them according to each individual’s symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",100.0
657,PRECIS-2,Eighty people completed baseline testing.,fulltext,Eighty persons completed baseline testing.,92.6829268292683
657,PRECIS-2,"The study was approved by the Regional Committees for Medical and Health Research Ethics in Norway, and the study complied with the Declaration of Helsinki.",fulltext,"The study was approved by the Regional Committees for Medical and Health Research Ethics in Norway, and the study complied with the Declaration of Helsinki.",100.0
657,PRECIS-2,"To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.",fulltext,"To examine possible differences between groups over time, we performed an intention-to-treat analysis using repeated-measures mixed models in IBM SPSS Version 24.",100.0
657,PRECIS-2,All group members received a booklet with illustrations of the exercises in which the physical therapist prescribed unsupervised home exercises to be conducted twice per week for 30 minutes.,fulltext,All group members received a booklet with illustrations of the exercises in which the physical therapist prescribed unsupervised home exercises to be conducted twice per week for 30 minutes.,100.0
657,PRECIS-2,"All participants with postintervention test assessment scores were included, although some had missing observations.",fulltext,"All participants with postintervention test assessment scores were included, although some had missing observations.",100.0
657,PRECIS-2,657.pdf,prompt,015.pdf,71.42857142857143
657,PRECIS-2,Exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.,fulltext,Exclusion criteria were as follows: (1) pregnancy at time of examination; (2) exacerbation in the previous 2 weeks before enrollment; and (3) other acute conditions compromising balance.,100.0
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",100.0
657,PRECIS-2,Participants allocated to the intervention group were divided into 13 training groups by B.N. and E.C.A. according to geography.,fulltext,Participants allocated to the intervention group were divided into 13 training groups by B.N. and E.C.A. according to geography.,100.0
657,PRECIS-2,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic, had EDSS scores of 0 to 7, and lived in 1 of the 6 municipalities included in the study.",100.0
657,PRECIS-2,Assessments at all time points took place at a Norwegian hospital.,fulltext,Assessments at all time points took place at a Norwegian hospital.,100.0
657,PRECIS-2,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",fulltext,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days.,100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training.,100.0
657,PRECIS-2,"The outcome measures were the Trunk Impairment Scale–Norwegian Version (TIS-NV), the Mini Balance Evaluation Systems Test (Mini-BESTest), and the Patient Global Impression of Change–Balance (PGIC-Balance).",fulltext,"The outcome measures were the Trunk Impairment Scale–Norwegian Version (TIS-NV), the Mini Balance Evaluation Systems Test (Mini-BESTest), and the Patient Global Impression of Change–Balance (PGIC-Balance).",100.0
662,PRECIS-2,Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.,fulltext,Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.,100.0
662,PRECIS-2,662.pdf,prompt,015.pdf,57.14285714285714
662,PRECIS-2,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.",fulltext,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies.",100.0
662,PRECIS-2,The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.,fulltext,The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.,100.0
662,PRECIS-2,"Participants completed online questionnaires at baseline (prior to randomisation), post-intervention and three-month follow-up.",fulltext,"Participants completed online questionnaires at baseline (prior to randomisation), post-intervention and three-month follow-up.",100.0
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,"Finally, people were excluded if they reported any serious psychological disorders (e.g. psychosis, substance abuse), severe hearing impairment, attending other psychological therapies or prior formal training in mindfulness.",fulltext,"Finally, people were excluded if they reported any serious psychological disorders (e.g. psychosis, substance abuse), severe hearing impairment, attending other psychological therapies or prior formal training in mindfulness.",100.0
662,PRECIS-2,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M)",fulltext,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M)",100.0
662,PRECIS-2,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",fulltext,"AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner.",100.0
663,PRECIS-2,A follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext, follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,99.2
663,PRECIS-2,"Participating staff at MS clinics: Department of neurology, Aarhus University Hospital; Department of neurology, Odense University Hospital; Department of neurology, Regional Hospital West Jutland; Department of neurology, Viborg Regional Hospital; Department of neurology, Hospital Lillebaelt; Department of neurology, Hospital South West Jutland; and Department of neurology, Hospital of Southern Jutland.",fulltext,"Participating staff at MS clinics: Department of neurology, Aarhus University Hospital; Department of neurology, Odense University Hospital; Department of neurology, Regional Hospital West Jutland; Department of neurology, Viborg Regional Hospital; Department of neurology, Hospital Lillebaelt; Department of neurology, Hospital South West Jutland; and Department of neurology, Hospital of Southern Jutland.",100.0
663,PRECIS-2,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",100.0
663,PRECIS-2,Primary outcomes were walking speed assessed by the T25FW and complex walking assessed by the SSST.,fulltext,primary outcomes were walking speed assessed by the T25FW 20 and complex walking assessed by the SSST.,100.0
663,PRECIS-2,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers.",fulltext,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,PRECIS-2,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,fulltext,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,100.0
663,PRECIS-2,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,PRECIS-2,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",fulltext,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",100.0
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",100.0
664,PRECIS-2,"The home-exercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance. Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.",fulltext,"The homeexercise sessions were intended to mirror the supervised sessions in terms of intensity and duration of aerobic exercise, and also included tailored exercises for strength, flexibility and balance. Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.",99.76133651551312
664,PRECIS-2,"Where appropriate, participants also performed exercises for strength and control. The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist (NS).",fulltext,"Where appropriate, participants also performed exercises for strength and control. The prescribed strength training was based on individual functional needs, as assessed by the trial physiotherapist (NS).",100.0
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",fulltext,"Outcomes were assessed at baseline, and at three months (post-intervention) and nine months after randomisation.",100.0
664,PRECIS-2,Exclusion criteria were comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.,fulltext,Exclusion criteria were comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.,100.0
664,PRECIS-2,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS. Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",fulltext,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS. 10,11 Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",100.0
664,PRECIS-2,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,fulltext,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,100.0
664,PRECIS-2,"Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment. Participants were asked to complete short bouts (e.g. 5 × 3 minutes, with two-minute rest intervals) of low to moderate intensity aerobic exercise (e.g. stepping ergometer, cycle-ergometer, treadmill walking, rowing ergometer, arm-cranking) at 50%–69% of predicted maximum heart rate (220–age) or 12–14 on the Borg Ratings of Perceived Exertion Scale.",fulltext,"Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment. Participants were asked to complete short bouts (e.g. 5 × 3 minutes, with twominute rest intervals) of low to moderate intensity aerobic exercise (e.g. stepping ergometer, cycle-ergometer, treadmill walking, rowing ergometer, arm-cranking) at 50%– 69% of predicted maximum heart rate (220–age) or 12–14 on the Borg Ratings of Perceived Exertion Scale.",99.8
664,PRECIS-2,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,fulltext,An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme.,100.0
664,PRECIS-2,Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial,fulltext,Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial,100.0
664,PRECIS-2,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
664,PRECIS-2,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
665,PRECIS-2,"The completion of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",fulltext,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",98.95287958115183
665,PRECIS-2,"Sheffield neurologists in the MS clinic, forms were completed and returned by 63 (21.8%) candidates from which we randomised 13 in 281 days (4.5% recruitment yield), or 1.4 participants per month. From the 250 recruitment packs sent out by post from The Walton Centre, forms were completed and returned by 64 (25.6%) of recipients, from which 10 participants were randomised in 149 days (4.0% recruitment yield), or two participants per month.",fulltext,"Sheffield neurologists in the MS clinic, forms were completed and returned by 63 (21.8%) candidates from which we randomised 13 in 281 days (4.5% recruitment yield), or 1.4 participants per month. From the 250 recruitment packs sent out by post from The Walton Centre, forms were completed and returned by 64 (25.6%) of recipients, from which 10 participants were randomised in 149 days (4.0% recruitment yield), or two participants per month.",100.0
665,PRECIS-2,"The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI. Specifically, we measured the mean change in scores between the two arms as measured at baseline, 8 and 21 weeks (13 weeks post intervention).",fulltext,"The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI. Specifically, we measured the mean change in scores between the two arms as measured at baseline, 8 and 21 weeks (13 weeks post intervention).",100.0
665,PRECIS-2,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21].",fulltext,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21])",100.0
665,PRECIS-2,"Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study. Although four out of five participating PCTs were happy to arrange alternative provision for those who did not have Internet access at home, all our participants requested home use of CCBT. In the Liverpool region, a specialist neuropsychologist, based in the acute hospital facilitated access to and provided technical advice on CCBT, but did not provide additional therapeutic input.",fulltext,"Only one out of the five participating PCTs around the Sheffield centre formally provided any kind of community facility for accessing CCBT; PCT staff warned that clients rarely used the facility and it was closed during the course of the study. Although four out of five participating PCTs were happy to arrange alternative provision for those who did not have Internet access at home, all our participants requested home use of CCBT. In the Liverpool region, a specialist neuropsychologist, based in the acute hospital facilitated access to and provided technical advice on CCBT, but did not provide additional therapeutic input.",100.0
665,PRECIS-2,"Invitations were made between October 2008 and July 2009: face-to-face by consultants in the Sheffield Teaching Hospitals NHS Foundation Trust MS clinic (n = 288); by the Sheffield MS nurses visiting patients (n = 4); and, using ink-signed personalised letters mailed out from a neuropsychologist at Sheffield (n = 40) as well as from consultant neurologists at the Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool (n = 250).",fulltext,"Invitations were made between October 2008 and July 2009: face-to-face by consultants in the Sheffield Teaching Hospitals NHS Foundation Trust MS clinic (n = 288); by the Sheffield MS nurses visiting patients (n = 4); and, using ink-signed personalised letters mailed out from a neuropsychologist at Sheffield (n = 40) as well as from consultant neurologists at the Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool (n = 250).",100.0
665,PRECIS-2,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",fulltext,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",100.0
665,PRECIS-2,Participants were contacted if they failed to keep trial appointments.,prompt,Patients are contacted if they fail to keep trial appointments.,87.14285714285714
665,PRECIS-2,"In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine service provided to all patients referred to the PCT mental health care teams.",fulltext,"In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine Patients approached to take p",85.64356435643565
666,PRECIS-2,Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria),fulltext,Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria),100.0
666,PRECIS-2,The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied),fulltext,The primary endpoint was patient overall satisfaction with the medication as measured by the single-item MSQ 7-point scale (1 = extremely dissatisfied to 7 = extremely satisfied),100.0
666,PRECIS-2,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",fulltext,"The intention-to-treat (ITT) analysis set included all randomly assigned participants and were analyzed according to the treatment group to which they were randomly assigned, regardless of which treatment they actually received.",100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",fulltext,"Five scheduled visits at study sites occurred at screening (within 2 weeks prior to baseline), baseline (Month 0), and Months 1, 3, and 6 (end of the core phase).",100.0
666,PRECIS-2,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",fulltext,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",100.0
666,PRECIS-2,"Patients also participated in self-reported, daily at-home MSQ assessments on Days 1 through 7 after the baseline visit.",fulltext,"Patients also participated in self-reported, daily athome MSQ assessments on Days 1 through 7 after the baseline visit.",99.16666666666667
666,PRECIS-2,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment.",fulltext,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment.",100.0
666,PRECIS-2,Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430).,fulltext,Eligible patients were randomly assigned 1:1 to receive subcutaneous injections of GA40 (n = 431) or GA20 (n = 430).,100.0
668,PRECIS-2,"The training also took the form of small group-based training; this is important because it made exercising a more social activity, and it was more cost effective and time efficient than individual training.",fulltext,"The training also took the form of small group-based training; this is important because it made exercising a more social activity, and it was more cost effective and time efficient than individual training.",100.0
668,PRECIS-2,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch.,fulltext,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch.,100.0
668,PRECIS-2,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",fulltext,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",fulltext,"While these were the core exercises, they could be individualized. For example, if any exercise caused discomfort, the starting position was modified or the exercise was replaced.",100.0
668,PRECIS-2,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.",fulltext,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers). Each trainer directly supervised a sub-group of three or four participants.",100.0
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic. To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with Dodd et al. 1363 MS, and a large specialist MS outpatient clinic. To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,Changes in walking endurance were measured with the 2-minute walk test (2MWT).,fulltext,Changes in walking endurance were measured with the 2-minute walk test (2MWT).,100.0
668,PRECIS-2,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",fulltext,"Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations. If interested, volunteers were asked to contact one of the researchers (KD) by telephone, during which volunteers were screened to ensure they satisfied the inclusion criteria.",100.0
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.",fulltext,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis. Where data were missing, the carry forward technique was used.",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",100.0
669,PRECIS-2,"Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant. If a participant had been inactive, a phone call was made for enquiry. Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",fulltext,"Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant. If a participant had been inactive, a phone call was made for enquiry. Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",100.0
669,PRECIS-2,Interested pwMS attended an information session and jointly walked 5 km for verification of their ability.,fulltext,Interested pwMS attended an information session and jointly walked 5 km for verification of their ability.,100.0
669,PRECIS-2,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,fulltext,Exclusion criteria were reports to have run 5 km in the preceding 6 months or a relapse occurring in the preceding 3 months.,100.0
669,PRECIS-2,"Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis",fulltext,"Effects of an individual 12-week communitylocated “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons with multiple sclerosis",99.4949494949495
669,PRECIS-2,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,100.0
669,PRECIS-2,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,fulltext,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,100.0
669,PRECIS-2,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",fulltext,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",100.0
669,PRECIS-2,Evaluation was performed at two time points (0 and 12 weeks).,fulltext,atients were tested at two time points (0 and 12 weeks).,77.04918032786885
669,PRECIS-2,Participants in the training group adhered well to the remotely supervised program while showing low adverse event rates.,fulltext,Participants in the training group adhered well to the remotely supervised program while showing low adverse event rates.,100.0
669,PRECIS-2,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",fulltext,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",100.0
669,PRECIS-2,Intention-to-treat analysis was performed.,fulltext,Intention-to-treat analysis was performed.,100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",100.0
669,PRECIS-2,An illustration of a training protocol is provided in supplementary material S1.,fulltext,An illustration of a training protocol is provided in supplementary material S1.,100.0
670,PRECIS-2,"The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs. These included effleurage, petrissage, stroking, frictions, vibrations, tapotment, rocking and shaking, details of which have been reviewed by Yates (2004). These techniques all involve the manipulation of soft tissues to which was added joint mobilization, myofascial techniques, rehabilitative exercise and hydrotherapy in order to reflect the broad therapeutic armamentarium of the massage therapist.",fulltext,"The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs. These included effleurage, petrissage, stroking, frictions, vibrations, tapotment, rocking and shaking, details of which have been reviewed by Yates (2004). These techniques all involve the manipulation of soft tissues to which was added joint mobilization, myofascial techniques, rehabilitative exercise and hydrotherapy in order to reflect the broad therapeutic armamentarium of the massage therapist.",100.0
670,PRECIS-2,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",100.0
670,PRECIS-2,670.pdf,prompt,015.pdf,71.42857142857143
670,PRECIS-2,"Massage therapy is aligned with the wellness paradigm of health and health care (Alexander, 2006; Yates, 2004), which speaks to a holistic client centered approach to treatment. Accordingly, if the current research was to conform to the requirements of model fit/ecological validity (Menard, 2003; Mason et al., 2002), it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client’s physical, psychological and emotional needs. The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.",fulltext,"Massage therapy is aligned with the wellness paradigm of health and health care (Alexander, 2006; Yates, 2004), which speaks to a holistic client centered approach to treatment. Accordingly, if the current research was to conform to the requirements of model fit/ecological validity (Menard, 2003; Mason et al., 2002), it was incumbent on the therapists to construct individualized treatment plans recognizing the importance of the client’s physical, psychological and emotional needs. The heterogeneity of the client/participant population precluded an overly prescriptive approach to treatment, and it is worth noting that this heterogeneity is also a component of the normal clinical reality of therapists involved with multiple sclerosis clients.",100.0
670,PRECIS-2,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population.",100.0
670,PRECIS-2,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
670,PRECIS-2,"The nature of the MSSE survey is such that the clients’ self-efficacy rating is captured through a series of eighteen questions to which they respond on a scale ranging from ten to one hundred. The instrument focuses on the clients’ perception of their ability to function, and the degree of control they have within the context of their disease state.",fulltext,"The nature of the MSSE survey is such that the clients’ self-efficacy rating is captured through a series of eighteen questions to which they respond on a scale ranging from ten to one hundred. The instrument focuses on the clients’ perception of their ability to function, and the degree of control they have within the context of their disease state.",100.0
670,PRECIS-2,"In the context presented above, the use of MSSE scores as the outcome measure in the current research reflects the notion that massage therapy has the potential to improve client well-being and adjustment to living with multiple sclerosis, through improving perceptions of function and control.",fulltext,"In the context presented above, the use of MSSE scores as the outcome measure in the current research reflects the notion that massage therapy has the potential to improve client well-being and adjustment to living with multiple sclerosis, through improving perceptions of function and control.",100.0
670,PRECIS-2,"An appropriate history and physical examination was performed, and a treatment plan determined, this being reflective of the therapist’s assessment and the mutually set goals for the treatment series.",fulltext,"An appropriate history and physical examination was performed, and a treatment plan determined, this being reflective of the therapist’s assessment and the mutually set goals for the treatment series.",100.0
670,PRECIS-2,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,fulltext,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",100.0
670,PRECIS-2,"With respect to the ambulatory status of the participants, six walked unassisted, five used a cane, and four used a walker. All participants had prior experience of massage treatment at the clinic.",fulltext,"With respect to the ambulatory status of the participants, six walked unassisted, five used a cane, and four used a walker. All participants had prior experience of massage treatment at the clinic.",100.0
670,PRECIS-2,"For both treatment and control groups, self-efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.625468164794
670,PRECIS-2,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis. The time since diagnosis ranged from three to forty-one years (with a mean of 19 years) at the time of the study. Nine participants were categorized as Relapse eRemitting, four as Secondary Progressive and two as Primary Progressive.",fulltext,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis. The time since diagnosis ranged from three to forty-one years (with a mean of 19 years) at the time of the study. Nine participants were categorized as Relapse eRemitting, four as Secondary Progressive and two as Primary Progressive.",100.0
670,PRECIS-2,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",100.0
671,PRECIS-2,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treatment within the preceding month, or participating in another clinical trial.",fulltext,"Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treat ment within the preced ing month, or participating in another clinical trial.",100.0
671,PRECIS-2,"Outcome assessors (research therapists) were masked to treatment allocation, and all assessments were done independently and away from the participant’s home.",fulltext,"Outcome assessors (research therapists) were masked to treatment allocation, and all assessments were done independently and away from the participant’s home.",100.0
671,PRECIS-2,"In line with previous research, participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"In line with previous research, 14 participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis (primary or secondary) according to McDonald’s criteria, and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of pro gressive multiple sclerosis (primary or secondary) accord ing to McDonald’s criteria, 21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS).",100.0
671,PRECIS-2,"The AMCA score (range 0–76) is the sum of two subscores. The functional activity subscore (16 items, each scored 0–3) comprises key functional activities of the trunk and lower limbs, such as rolling in bed, sit-to stand, and sitting and standing balance. The lower limb movement subscore (14 items, each scored 0–2) rates motor impairment by grading hip and knee flexion and knee flexion and dorsiflexion in lying, sitting, and standing positions.",fulltext,"The AMCA score (range 0–76) is the sum of two subscores. The functional activity subscore (16 items, each scored 0–3) comprises key functional activities of the trunk and lower limbs, such as rolling in bed, sit to stand, and sitting and standing balance. The lower limb movement subscore (14 items, each scored 0–2) rates motor impairment by grading hip and knee flexion and knee flexion and dorsiflexion in lying, sitting, and standing positions.",100.0
671,PRECIS-2,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",fulltext,"The intervention consisted of two home-based physiotherapy sessions (60 min each) to set up the standing frame programme, supported by six follow-up telephone calls (15 min per call).",100.0
671,PRECIS-2,The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at the primary endpoint of 36 weeks post-randomisation.,fulltext,The prim ary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score 23 at the primary endpoint of 36 weeks post randomisation.,100.0
671,PRECIS-2,Validated outcome measures included clinician rated assessments and self-reported questionnaires. The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at the primary endpoint of 36 weeks post-randomisation.,fulltext,Validated outcome measures included clinician rated assessments and self reported questionnaires. The prim ary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score 23 at the primary endpoint of 36 weeks post randomisation.,100.0
671,PRECIS-2,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,fulltext,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,100.0
671,PRECIS-2,This allowed for a graduated introduction to standing.,fulltext,This allowed for a graduated introduction to standing.,100.0
671,PRECIS-2,"The use of standing frames is a recognised core skill for UK trained neurological physiotherapists. To standardise and optimise implementation of the intervention, we provided educational materials and assessed fidelity to them.",fulltext,"The use of standing frames is a recognised core skill for UK trained neurological physiotherapists. To standardise and optimise implementation of the intervention, we provided educational materials and assessed fidelity to them.",100.0
671,PRECIS-2,"The primary analysis population was defined as all participants who completed baseline and 36 week assessments. The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (i.e., there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",fulltext,"The primary analysis population was defined as all participants who completed baseline and 36 week assess ments. The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the inter vention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",99.69788519637463
671,PRECIS-2,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
673,PRECIS-2,"This was a multi-centre, block randomised, assessor blind, controlled study. The methods of the trial were previously described in detail. This paper presents the results of the study participants, who used at the most unilateral support to walk outdoors",fulltext,"This was a multi-centre, block randomised, assessor blind, controlled study. The methods of the trial were previously described in detail. 10 Participants This paper presents the results of the study participants, who used at the most unilateral support to walk outdoors",100.0
673,PRECIS-2,"Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors.",fulltext,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors.",100.0
673,PRECIS-2,"Participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,PRECIS-2,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",99.48979591836735
673,PRECIS-2,All participants were analysed in the groups to which they were randomised.,fulltext,All participants were analysed in the groups to which they were randomised.,100.0
673,PRECIS-2,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,fulltext,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,100.0
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",100.0
673,PRECIS-2,"It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",fulltext,"It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",100.0
673,PRECIS-2,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,fulltext,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,PRECIS-2,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to the control or an intervention.",fulltext,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to the control or an intervention.",100.0
674,PRECIS-2,Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients,fulltext,Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients,100.0
674,PRECIS-2,"In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-β-1a 44 mg and alemtuzumab 12 mg, respectively.",fulltext," In total, 202 and 426 CARE-MS II patients were randomized to SC IFN-b-1a 44 mg and alemtuzumab 12 mg, respectively",98.26086956521739
674,PRECIS-2,Differences in study drug administration and unique adverse event profiles precluded effective double-blinding.,fulltext, Differences in study drug administration and unique adverse event profiles precluded effective double-blinding,99.09909909909909
674,PRECIS-2,"An intention-to-treat analysis has recently also become the norm for superiority trials taking a more explanatory design approach, especially when regulatory approval for an intervention is being sought.",prompt,"e intention-to-treat analysis has recently also become the norm for superiority trials taking a more explanatory design approach, especially when regulatory approval for an intervention is being sought",98.52216748768473
674,PRECIS-2,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",fulltext,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",100.0
674,PRECIS-2,EDSS-based and non-EDSS-based methods. The results of these prespecified outcomes and post hoc analyses from CARE-MS II more fully characterize the effects of alemtuzumab on disability in patients with RRMS than those published previously,fulltext, EDSS-based and non-EDSSbased methods. The results of these prespecified outcomes and post hoc analyses from CARE-MS II more fully characterize the effects of alemtuzumab on disability in patients with RRMS than those published previousl,99.15966386554622
674,PRECIS-2,"CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-β-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs (≥1 relapse during IFN-β or glatiramer acetate [GA] treatment [received for ≥6 months]).",fulltext," CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-b-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs ($1 relapse during IFN-b or glatiramer acetate [GA] treatment [received for $6 months])",99.34924078091106
674,PRECIS-2,"Raters administered the MSFC 3 times before baseline to attenuate practice effects, then every 6 months.",fulltext," Raters administered the MSFC 16 3 times before baseline to attenuate practice effects, then every 6 months",99.03846153846155
674,PRECIS-2,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis II (CARE-MS II), a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 mg in patients with RRMS.",fulltext,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-b-1a (SC IFN-b-1a) 44 mg in patients with RRMS.",97.95918367346938
675,PRECIS-2,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).",fulltext,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0).",100.0
675,PRECIS-2,"MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial",fulltext,"MS quality of life, depression, and fatigue improve after mindfulness training A randomized trial",98.9795918367347
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills. Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions. Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience. The all-day retreat integrated familiar exercises and presented new ones. In all, 6 MBI courses for the experimental arm of the study were individually conducted by 2 experienced, certified teachers, each with ≥9 years teaching experience.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills. Each class covered specific exercises and topics within the context of mindfulness training, i.e., practices during lying, sitting, and dynamic yoga postures, as well as during everyday life, e.g., stressful situations and social interactions. Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience. The all-day retreat integrated familiar exercises and presented new ones. In all, 6 MBI courses for the experimental arm of the study were individually conducted by 2 experienced, certified teachers, each with 9 years teaching experience.",100.0
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,Reported outcome measurements occurred within 2 weeks before and after intervention and 6 months postintervention.,fulltext,Reported outcome measurements occurred within 2 weeks before and after intervention and 6 months postintervention.,100.0
675,PRECIS-2,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS and 2) an Expanded Disability Status Scale (EDSS) score of ≤6 (no to moderately severe disability), with ≤1 step increase within the last year. Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",fulltext,"Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS 21 and 2) an Expanded Disability Status Scale (EDSS) 22 score of 6 (no to moderately severe disability), with 1 step increase within the last year. Excluded were patients with reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety syndromes, evidence of dementia as indicated by testing below the fifth percentile in at least 3 of 6 dimensions of neuropsychological functioning (i.e., attention and concentration, processing speed, executive function, verbal memory, and verbal processing), other currently life-threatening or severely disabling physical disorders, current MS exacerbation, symptomatic MS medication altered in the last 3 months, other disorders of the CNS, pregnancy, or inability to speak or read German.",100.0
677,PRECIS-2,"The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week. The following exercises are part of the H-CAD system: key, light bulb, book, jar, writing, checkers and keyboard tasks.",fulltext,"the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week. the following exercises are part of the H-caD system: key, light bulb, book, jar, writing, checkers and keyboard tasks.",100.0
677,PRECIS-2,All measurements were performed at the centre where the patient had been treated.,fulltext,All measurements were performed at the centre where the patient had been treated.,100.0
677,PRECIS-2,"exclusions were: a) disturbed upper limb function not related to MS, TBI or stroke; B) serious cognitive and/or behavioral problems; c) serious emotional problems; D) major visual problems; (e) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.",fulltext,"exclusions were: a) disturbed upper limb function not related to MS, tBI or stroke; B) serious cognitive and/or behavioral problems; c) serious emotional problems; D) major visual problems; (e) communication problems; F) medical complications; G) other problems possibly contra-indicating autonomous exercise at home.",100.0
677,PRECIS-2,The overall satisfaction of both patients and therapists concerning the H-CAD system was high.,fulltext,the overall satisfaction of both patients and therapists was high.,70.2127659574468
677,PRECIS-2,677.pdf,prompt,015.pdf,57.14285714285714
677,PRECIS-2,The second measurement (t1) was performed after the month of usual care (for intervention as well as control group). The third measurement (t2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group. A month after t2 a follow up measurement was performed (t3) for the intervention group. The control group received their last measurement (t3) 4 months after baseline.,fulltext,the second measurement (t1) was performed after the month of usual care (for intervention as well as control group). the third measurement (t2) was performed after the month of H-caD intervention for the intervention group and 2 months after baseline for the control group. a month after t2 a follow up measurement was performed (t3) for the intervention group. the control group received their last measurement (t3) 4 months after baseline.,100.0
677,PRECIS-2,"The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (IcF) model.",fulltext,"The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (IcF) model.",100.0
677,PRECIS-2,"Patients were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or TBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",fulltext,"patients. the subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or tBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",100.0
677,PRECIS-2,"Patients were recruited from Unità Organica di riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis centre (NMSc, Belgium).",fulltext,"Patients were recruited from Unità Organica di riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis centre (NMSc, Belgium).",100.0
678,PRECIS-2,Is Short-Term Palliative Care Cost-Effective in Multiple Sclerosis? A Randomized Phase II Trial,fulltext,Is Short-Term Palliative Care Cost-Effective in Multiple Sclerosis? A Randomized Phase II Trial,100.0
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial.",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial.",100.0
678,PRECIS-2,"Patients had one to three contacts (visits and/or phone calls) from the PCT, although a small number (around 12%) were referred for longer-term ‘‘community’’ palliative care.",fulltext,"Patients had one to three contacts (visits and/or phone calls) from the PCT, although a small number (around 12%) were referred for longer-term ‘‘community’’ palliative care.",100.0
678,PRECIS-2,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT.",fulltext,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT.",100.0
678,PRECIS-2,"At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05e7.89) in the fast track compared to the control group.",fulltext,"At 12 weeks, caregiver burden was 4.47 points lower (95% confidence interval [CI]: 1.05e7.89) in the fast track compared to the control group.",100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,fulltext,Exclusion criteria included if the referring staff or the screening deemed patients had very urgent needs or were deteriorating rapidly when immediate referral to the service was offered.,100.0
678,PRECIS-2,"The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",fulltext,"The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",100.0
678,PRECIS-2,"This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",fulltext,"This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",100.0
678,PRECIS-2,We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers.,fulltext,We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers.,100.0
678,PRECIS-2,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,PRECIS-2,There was a trend toward a reduction in pain in the fast-track group and an increase in the control group (with an effect size of 0.6 and a total sample size required to detect this is 56).,fulltext,There was a trend toward a reduction in pain in the fast-track group and an increase in the control group (with an effect size of 0.6 and a total sample size required to detect this is 56).,100.0
678,PRECIS-2,"Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",fulltext,"Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",100.0
678,PRECIS-2,"Inclusion criteria were patients in South East London, living with MS",fulltext,"Inclusion criteria were patients in South East London, living with MS",100.0
678,PRECIS-2,"Data were collected at baseline, 6, 12, 18 (only control groupdafter they received PCT), and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.",fulltext,"Data were collected at baseline, 6, 12, 18, and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.",74.57627118644068
679,PRECIS-2,679.pdf,prompt,015.pdf,57.14285714285714
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",100.0
679,PRECIS-2,"CDTs were given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",fulltext,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",97.83783783783784
679,PRECIS-2,"Intention-to-treat ANCOVA analyses were performed with follow-up values as dependent, and condition, baseline values, disease duration and gender as independent variables.",fulltext,"Intention-to-treat ANCOVA analyses were performed with follow-up values as dependent, and condition, baseline values, disease duration and gender as independent variables.",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires",100.0
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,PRECIS-2,"Components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional)",fulltext,"components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional)",100.0
679,PRECIS-2,Primary endpoint was control self-efficacy (Multiple Sclerosis Self-Efficacy Scale Control [MSSES-C]) at six months.,fulltext,"Primary endpoint was control self-efficacy (Multiple Sclerosis Self-Efficacy Scale Control [MSSES-C] (minimum 90, maximum 900) at six months.",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",100.0
680,PRECIS-2,Inclusion criteria: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II),fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II),100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital",100.0
680,PRECIS-2,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,"Exclusion criteria: Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",prompt,"Exclusion criteria—Pregnancy, breast feeding, uncontrolled diabetes, peptic ulcer disease, suppurative otitis media, herpes zoster, multiple sclerosis, systematic infection, sarcoidosis and other rare conditions, and an inability to provide informed consent.",99.61389961389962
680,PRECIS-2,The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies.,fulltext,The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies.,100.0
680,PRECIS-2,"Follow up assessments ended April, 2015.",fulltext,"Follow up assessments ended April, 2015.",100.0
680,PRECIS-2,"To examine group differences at post and 20 week follow up assessment, individual analyses of covariance (ANCOVAs) were performed with baseline treatment outcome scores used as the covariate.",fulltext,"ariables. To examine group differences at post and 20 week follow up assessment, individual analyses of covariance (ANCOVAs) were performed with baseline treatment outcome scores used as the ",94.76439790575917
680,PRECIS-2,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II),fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II),100.0
680,PRECIS-2,All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.,fulltext,All participants completed questionnaires at pre- and post-treatment and at 20 weeks follow up.,100.0
680,PRECIS-2,680.pdf,prompt,015.pdf,71.42857142857143
680,PRECIS-2,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
681,PRECIS-2,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination and access to the intervention sites using their own or public transport.",fulltext,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale 33 score of 5 (ambulatory without aid or rest for 580 Clinical Rehabilitation 26(7) about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination 34 and access to the intervention sites using their own or public transport.",100.0
681,PRECIS-2,The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,fulltext,The Timed 25Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,99.6
681,PRECIS-2,Potential participants (n 1⁄4 159) were sent invitation letters and participant information sheets.,fulltext, were sent invitation letters and participant information sheets.,65.65656565656566
681,PRECIS-2,"From those living near Site A a list of potential participants (n 1⁄4 16) was created and, to maximise class occupancy, 10 potential participants were allocated to Site A’s intervention group. A similar system was used for Site B (which had a class capacity of 12), for which a list of potential participants (n 1⁄4 20) was created.",fulltext,"From those living near Site A a list of potential participants (n ¼ 16) was created and, to maximise class occupancy, 10 potential participants were allocated to Site A’s intervention group. A computer program (Microsoft Excel 2003) was set up to randomly assign the 10 people to the exercise group and 6 to the control group. A similar system was used for Site B (which had a class capacity of 12), for which a list of potential participants (n ¼ 20) was created.",98.19277108433735
681,PRECIS-2,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",fulltext,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,The same physiotherapist was present at both sites; however fitness instructors were different between sites.,fulltext,The same physiotherapist was present at both sites; however fitness instructors were different between sites.,100.0
681,PRECIS-2,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed.",fulltext,"Through discussion with the instructors, participants chose which level of each exercise they deemed appropriate and also when and how each exercise should be progressed.",100.0
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,Thus 36 people were invited for screening.,fulltext,Thus 36 people were invited for screening.,100.0
681,PRECIS-2,Each group was led by two instructors (one physiotherapist and one fitness instructor).,fulltext,Each group was led by two instructors (one physiotherapist and one fitness instructor).,100.0
681,PRECIS-2,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
681,PRECIS-2,Participants worked at a self-regulated pace for each exercise.,fulltext,Participants worked at a self-regulated pace for each exercise.,100.0
681,PRECIS-2,681.pdf,prompt,015.pdf,71.42857142857143
682,PRECIS-2,"Participants in both groups received two private training sessions with the physical therapist or exercise therapist. For the MSTEP© group, the sessions were used to assess individual needs and design an individualized programme. For the Guideline group, the sessions were used to instruct on the guidelines and learn how to apply principles of safe and effective exercise. All were provided with a portfolio of exercise instructions.",fulltext,"Participants in both groups received two private training sessions with the physical therapist or exercise therapist. For the MSTEP© group, the sessions were used to assess individual needs and design an individualized programme. For the Guideline group, the sessions were used to instruct on the guidelines and learn how to apply principles of safe and effective exercise. All were provided with a portfolio of exercise instructions.",100.0
682,PRECIS-2,"All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months.",fulltext,"All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months.",100.0
682,PRECIS-2,"The trial received ethical approval from the Montreal Neurological Hospital Research Ethics Board (NEU-12-005) and the Health Research Ethics Board, University of Manitoba (H2014:226)",fulltext,"The trial received ethical approval from the Montreal Neurological Hospital Research Ethics Board (NEU-12-005) and the Health Research Ethics Board, University of Manitoba (H2014:226)",100.0
682,PRECIS-2,"Inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ≤5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities); and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",fulltext,"inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",99.76525821596243
682,PRECIS-2,Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.,fulltext,Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.,100.0
682,PRECIS-2,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,fulltext,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,100.0
682,PRECIS-2,"During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility. Those contacting the research team directly were assessed for eligibility over the phone and sent information on the study electronically.",fulltext,"During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility. Those contacting the research team directly were assessed for eligibility over the phone and sent information on the study electronically.",100.0
682,PRECIS-2,"The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed and have a further follow-up after the second year. As there were substantial losses to follow-up, only results after one year are presented.",fulltext,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed exercise-induced fatigue predicted retention. There were no,62.807017543859644
682,PRECIS-2,"The MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",fulltext,"The MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",100.0
682,PRECIS-2,The primary outcome was exercise capacity as measured by peak oxygen consumption (VO2peak) using a modified Bruce protocol on the cycle ergometer.,fulltext,The primary outcome was exercise capacity as measured by peak oxygen consumption (VO 2peak ) using a modified Bruce protocol on the cycle ergometer.,100.0
684,PRECIS-2,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",fulltext,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",100.0
684,PRECIS-2,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",fulltext,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",100.0
684,PRECIS-2,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, 12 was the primary outcome measure for the study.",100.0
684,PRECIS-2,"To improve the reliability of the data, all assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation.",fulltext,"To improve the reliability of the data, all assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation.",100.0
684,PRECIS-2,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over and had at least three identifiable physiotherapy goals were included.",fulltext,"People with MS who were medically stable were selected where cognitive function was adequate, as assessed by a Mini Mental State Examination score of 23 or over 11 and had at least three identifiable physiotherapy goals were included.",100.0
684,PRECIS-2,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,fulltext,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,100.0
684,PRECIS-2,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self-care functions and generally has effective use of arms).",fulltext,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many selfcare functions and generally has effective use of ",98.11320754716981
684,PRECIS-2,684.pdf,prompt,015.pdf,57.14285714285714
684,PRECIS-2,"Each subject therefore received core treatments aimed to maximize strength, flexibility and function.",fulltext,"Each subject therefore received core treatments aimed to maximize strength, flexibility and function.",100.0
684,PRECIS-2,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",fulltext,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",100.0
684,PRECIS-2,"Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",fulltext,"Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",100.0
684,PRECIS-2,"Where there were problems with missing data due to dropouts/non-completion, the simple repeated measures ANOVA was replaced with a general linear model where missing data are estimated within the model.",fulltext,"Where there were problems with missing data due to dropouts/non-completion, the simple repeated measures ANOVA was replaced with a general linear model where missing data are estimated within the model.",100.0
685,PRECIS-2,As findings from the Delphi study highlighted the need for flexibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,fulltext,As  ndings from the Delphi study highlighted the need for  exibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,98.4
685,PRECIS-2,"Individuals were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes.",fulltext,"Individuals were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes.",100.0
685,PRECIS-2,Missing values on scales were replaced with group means for each outcome measure. It was not possible to perform an ‘intention to treat’ analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.,fulltext,Missing values on scales were replaced with group means for each outcome measure. It was not possible to perform an ‘intention to treat’ analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.,100.0
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner.,98.0
685,PRECIS-2,"Total scores on a postal version of the Barthel Index, a scale measuring mobility, the SF-36, and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",fulltext,"Total scores on a postal version of the Barthel Index, 11 a scale measuring mobility, 12 the United Kingdom version of the SF-36 13 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",100.0
685,PRECIS-2,Follow-up assessments were conducted six months after baseline.,fulltext, assessments were conducted six months after baseline.,85.71428571428572
685,PRECIS-2,The blind code was broken after the final follow-up assessments had occurred.,fulltext,The blind code was broken after the  nal follow-up assessments had occurred.,97.40259740259741
685,PRECIS-2,"It was a community-based research study, which was approved by the appropriate local research ethics committees, and was conducted at the Centre for Research in Rehabilitation at Brunel University’s Osterley Campus in West London from June 1996 until February 1999.",fulltext,"It was a community-based research study, which was approved by the appropriate local research ethics committees, and was conducted at the Centre for Research in Rehabilitation at Brunel University’s Osterley Campus in West London from June 1996 until February 1999.",100.0
685,PRECIS-2,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",fulltext,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",100.0
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",100.0
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
685,PRECIS-2,Sessions were conducted either at participants’ homes or in local therapy centres.,fulltext,Sessions were conducted either at participants’ homes or in local therapy centres.,100.0
685,PRECIS-2,There were no exclusion criteria.,fulltext,There were no exclusion criteria.,100.0
685,PRECIS-2,685.pdf,prompt,015.pdf,71.42857142857143
686,PRECIS-2,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",100.0
686,PRECIS-2,Patients who were not living independently in the community were excluded.,fulltext,Patients who were not living independently in the community were excluded.,100.0
686,PRECIS-2,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a max-imum three-month period after inclusion. These patients received a half-day (four to six hours) indi-vidually tailored assessment by the multidisciplinary group.",fulltext,"re 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion. These patients received a half-day (four to six hours) individually tailored assessment by the multidisciplinary",96.84210526315789
686,PRECIS-2,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multi-disciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",fulltext,"2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsycholo",98.20627802690582
686,PRECIS-2,"In the control group, interventions with the different health professionals were planned after the inclusion visit, with an explanatory letter given to the patient or directly sent to the professionals.",fulltext,"In the control group, interventions with the different health professionals were planned after the inclusion visit, with an explanatory letter given to the patient or directly sent to the professionals.",100.0
686,PRECIS-2,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
686,PRECIS-2,686.pdf,prompt,015.pdf,57.14285714285714
686,PRECIS-2,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",fulltext,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",100.0
686,PRECIS-2,In most cases the same health professionals were in charge of the two groups.,fulltext,In most cases the same health professionals were in charge of the two groups.,100.0
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitie ́-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,fulltext,ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July,96.0
687,PRECIS-2,Of those 37 people expressed an interest in taking part.,fulltext,Of those 37 people expressed an interest in taking part.,100.0
687,PRECIS-2,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",fulltext,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, 13 stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",100.0
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,100.0
687,PRECIS-2,687.pdf,prompt,015.pdf,57.14285714285714
687,PRECIS-2,"Participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",fulltext,"Participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",100.0
687,PRECIS-2,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
687,PRECIS-2,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,fulltext,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part. Seven people were excluded as they did not meet the inclusion and exclusion criteria (Figure 1).",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate. Of those 37 people expressed an interest in taking part. Seven people were excluded as they did not meet the inclusion and exclusion criteria (Figure 1).",100.0
687,PRECIS-2,"The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population. The time taken to walk 25ft was recorded with a stop watch and a mean of two ‘walks’ recorded.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population. The time taken to walk 25ft was recorded with a stop watch and a mean of two ‘walks’ recorded.",100.0
688,PRECIS-2,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis and live in the Rome service area.",fulltext,"To be eligible, all patients screened for study participation had to be affected by clinically definite multiple sclerosis 17 and live in the ",88.53503184713377
688,PRECIS-2,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.",fulltext,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.",100.0
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,We assessed quality of life by means of SF-36.,fulltext,We assessed quality of life by means of SF-36.,100.0
688,PRECIS-2,The type of care was more than is normally available in the community through National Health Service care.,fulltext,The type of care was more than is normally available in the community through National Health Service care.,100.0
688,PRECIS-2,Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months.,fulltext,Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months.,100.0
688,PRECIS-2,688.pdf,prompt,015.pdf,57.14285714285714
688,PRECIS-2,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",100.0
688,PRECIS-2,Eligible patients were assessed for suitability by the coordinator of the home based care team (LP).,fulltext,Eligible patients were assessed for suitability by the coordinator of the home based care team (LP).,100.0
688,PRECIS-2,The study was conducted in Rome,fulltext,The study was conducted in Rome,100.0
689,PRECIS-2,"Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).",fulltext,"Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).",100.0
689,PRECIS-2,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months",100.0
689,PRECIS-2,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.).",fulltext,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.).",100.0
689,PRECIS-2,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score12 or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",fulltext,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score 12 or Renfrew et al. 3 relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",100.0
689,PRECIS-2,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet. Potential participants contacted the researchers if they were interested in participating.",100.0
689,PRECIS-2,689.pdf,prompt,015.pdf,57.14285714285714
689,PRECIS-2,"The angle of the tibia was inclined forward, approximately 10° to vertical, and each orthosis was ‘tuned’ by the addition or removal of small heel wedges.",fulltext,"The angle of the tibia was inclined forward, approximately 10° to vertical, and each orthosis was ‘tuned’ by the addition or removal of small heel wedges.",100.0
689,PRECIS-2,The primary aim of our study was to compare the clinical- and cost-effectiveness of ankle-foot orthoses and functional electrical stimulation over 12 months in people with Multiple Sclerosis presenting with foot drop.,fulltext,The primary aim of our study was to compare the clinical- and cost-effectiveness of ankle-foot orthoses and functional electrical stimulation over 12 months in people with Multiple Sclerosis presenting with foot drop.,100.0
689,PRECIS-2,"Against a background of financial constraints, there is a need for evidence of the cost benefits of interventions. Our study indicates that although the upfront costs of functional electrical stimulation are greater than usual care (ankle-foot orthoses), it may be considered as a potentially cost-effective treatment option for foot drop and offers a value for money alternative in Multiple Sclerosis.",fulltext,"Against a background of financial constraints, there is a need for evidence of the cost benefits of interventions. Our study indicates that although the upfront costs of functional electrical stimulation are greater than usual care (ankle-foot orthoses), it may be considered as a potentially cost-effective treatment option for foot drop and offers a value for money alternative in Multiple Sclerosis.",100.0
689,PRECIS-2,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment),13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",fulltext,"Participants were excluded if they had previously used functional electrical stimulation or an ankle-foot orthosis for foot drop, moderate to severe cognitive impairment (scored < 26, Montreal Cognitive Assessment), 13 foot drop due to other disorders, other conditions significantly affecting gait, contraindications to functional electrical stimulation, marked proximal weakness, plantar flexor spasticity, stance phase instability or severe lower limb/trunk ataxia affecting gait.",100.0
689,PRECIS-2,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,fulltext,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,100.0
689,PRECIS-2,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,fulltext,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,100.0
689,PRECIS-2,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment.",100.0
689,PRECIS-2,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services).",100.0
690,PRECIS-2,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",fulltext,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",100.0
690,PRECIS-2,"Other patient inclusion criteria were primary or secondary progressive MS, [1,13] Expanded Disability Status Scale (EDSS) score ≥ 8.0, [14] complex symptoms, [15] and ≥2 unmet care needs.",fulltext,"Other patient inclusion criteria were primary or secondary progressive MS, 1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs.",96.79144385026738
690,PRECIS-2,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",fulltext,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",100.0
690,PRECIS-2,"Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).",fulltext,"Dyads assigned to UC received the three examiner visits (visits 1–3) and the monthly telephone interviews, but not the HPA team visits (except visit 0).",100.0
690,PRECIS-2,All patient-carer dyads gave written informed consent before study enrollment.,fulltext,All patient-carer dyads gave written informed consent before study enrollment.,100.0
690,PRECIS-2,"The nurse (team leader) performed 152 visits (33%), followed by the psychologist (25%), the physician (25%), and the social worker (17%).",fulltext,". The nurse (team leader) performed 152 visits (33%), followed by the psychologist (25%), the physician (25%), and the social worker (17%",98.54014598540147
690,PRECIS-2,"Dyads were randomly assigned (2:1) to receive HPA or UC. Allocation to treatment groups was done using a third-party, web-based computerized randomization procedure with stratified minimization for EDSS score (8.0–8.5, 9.0–9.5), presence of severe cognitive compromise (clinical judgment), and center",fulltext,"Dyads were randomly assigned (2:1) to receive HPA or UC. Allocation to treatment groups was done using a third-party, web-based computerized randomization procedure with stratified minimization for EDSS score (8.0–8.5, 9.0–9.5), presence of severe cognitive compromise (clinical judgment), and center",100.0
690,PRECIS-2,"All team activities were recorded in the PeNSAMI patient study record, which was kept at the patient’s home and available to all HPs/caregivers.",fulltext,"All team activities were recorded in the PeNSAMI patient study record, which was kept at the patient’s home and available to all HPs/caregivers.",100.0
690,PRECIS-2,Participants were non-institutionalized adults (age ≥ 18 years) with severe MS and their primary carers.,fulltext,Participants were non-institutionalized adults (age ≥ 18 years) with severe MS and their primary carers.,100.0
690,PRECIS-2,"Based on the principles of PC, each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",fulltext,"Based on the principles of PC, 17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker.",100.0
690,PRECIS-2,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",fulltext,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POSS-MS).",99.32432432432432
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) and (3) ambulatory.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) 16 and (3) ambulatory.",100.0
691,PRECIS-2,"These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",fulltext,"These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), 18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) 19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",100.0
691,PRECIS-2,"The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",100.0
691,PRECIS-2,Individuals who had attended a fatigue management programme in the past year were excluded from the trial as were those who had received a fatigue intervention from a health professional in the past 3 months (see protocol).,fulltext,Individuals who had attended a fatigue management programme in the past year were excluded from the trial as were those who had received a fatigue intervention from a health professional in the past 3 months (see protocol).,100.0
691,PRECIS-2,691.pdf,prompt,015.pdf,71.42857142857143
691,PRECIS-2,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
691,PRECIS-2,"The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be easily replicated. A companion participant handbook, along with existing information booklets, reinforces programme content.",fulltext,"The facilitator manual provides guidance on preparation and delivery, detailed session content, notes and suggested timings, and a checklist of facilitator objectives as well as signposts to additional resources. Sessions are delivered via PowerPoint; hence can be easily replicated. A companion participant handbook, along with existing information booklets, reinforces programme content.",100.0
691,PRECIS-2,"The FACETS intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",fulltext,"The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",97.36842105263158
691,PRECIS-2,Outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.,fulltext,outcomes were measured 1 week (baseline) before the start of FACETS and 1 month (follow-up 1) and 4 months (follow-up 2) after the final session.,100.0
691,PRECIS-2,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).,fulltext,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).,100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
692,PRECIS-2,Practicing sessions were conducted under the supervision of a physical and sports activity trainer specializing in sports training.,fulltext,Practicing sessions were conducted under the supervision of a physical and sports activity trainer specializing in sports training.,100.0
692,PRECIS-2,Individuals participating in either a combination of PA and daily Mindfulness or a combination of PA and Implementation Intention.,fulltext,Individuals participated in either a combination of PA and daily Mindfulness or a combination of PA and Implementation Intention.,97.6923076923077
692,PRECIS-2,Implementation Intention Participants were asked to develop a concrete if-then plan (the “if” component followed by the “then” component) once a week and share them through the TB application. These combinations were intended to decrease fatigue and improve mobility among people with MS.,fulltext,Implementation Intention group (II) (n = 11) was asked to establish a concrete if-then plan (the ‘if ’ component 1 https://www.tailorbuilder.com/en/about.html followed by the ‘then’ component) once a week and share them through the TB application. These combinations were intended to decrease fatigue and improve mobility among people with MS.,94.44444444444444
692,PRECIS-2,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured by 6 min Walking Test (6MWT) (Guyatt et al., 1985) Modified Fatigue Impact Scale (MFIS) (Téllez et al., 2005), Health-related quality of life measured with EuroQoL (EQ5D-3L) (Goodwin et al., 2019) and Multiple Sclerosis Impact Scale (MSIS-29) (Hobart, 2001), respectively.",fulltext,"mobility, fatigue, quality of life and the impact of the disease on the patient’s life were measured by 6 min Walking Test (6MWT) (Guyatt et al., 1985) Modified Fatigue Impact Scale (MFIS) (Téllez et al., 2005), ",54.90196078431373
692,PRECIS-2,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,fulltext,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,100.0
692,PRECIS-2,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",fulltext,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",100.0
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",100.0
693,PRECIS-2,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana.",fulltext,"ssment Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Lju",94.92753623188406
693,PRECIS-2,"Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis",fulltext,"Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis",100.0
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,"Sports climbing (SC) took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License.",fulltext," sessions. SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee L",88.88888888888889
693,PRECIS-2,A physiotherapist assessed spasticity with Modified Ashworth Scale (MAS) [16].,fulltext,A physiotherapist assessed spasticity with Modified Ashworth Scale (MAS) [16].,100.0
694,PRECIS-2,694.pdf,prompt,015.pdf,57.14285714285714
694,PRECIS-2,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care, which remained unchanged.",99.62825278810409
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,PRECIS-2,Analyses were based on the modified intention-to-treat set (modified ITT).,fulltext, Analyses were based on the modified intention-totreat set (modified ITT),97.2972972972973
694,PRECIS-2,Hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)),fulltext,hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)),100.0
694,PRECIS-2,The primary endpoint was the change in the BBS (difference from BBS baseline to week 12).,fulltext,The primary endpoint was the change in the BBS 10–13 (difference from BBS baseline to week 12).,100.0
694,PRECIS-2,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion.,fulltext,MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion.,100.0
694,PRECIS-2,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,fulltext,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,100.0
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
695,PRECIS-2,"To inform the expert panel, an assessor carried out a broad-ranging baseline interview, which included the Braden scale for risk of skin sores,14 risk factors for falling,l and self-reported service utilization.",fulltext,"To inform the expert panel, an assessor carried out a broad-ranging baseline interview, which included the Braden scale for risk of skin sores,14 risk factors for falling,l and self-reported service utilization.",100.0
695,PRECIS-2,An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.,fulltext,An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.,100.0
695,PRECIS-2,"Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT",fulltext,"Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT",100.0
695,PRECIS-2,695.pdf,prompt,015.pdf,71.42857142857143
695,PRECIS-2,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",100.0
695,PRECIS-2,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",fulltext,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",100.0
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, UK).",fulltext,"The study took place between August 1997 and March 2000 and was approved by the research ethics committee of Queen's Medical Centre (Nottingham, ",97.31543624161074
695,PRECIS-2,"In the EG, baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being.",fulltext,"(EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being.",96.47058823529412
695,PRECIS-2,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",fulltext,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",100.0
695,PRECIS-2,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000).,fulltext,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000).,100.0
695,PRECIS-2,"To avoid ascertainment bias towards people already receiving specific health or social services, we used GP information as the sole method for identifying potential participants.",fulltext,"To avoid ascertainment bias towards people already receiving specific health or social services, we used GP information as the sole method for identifying potential participants.",100.0
695,PRECIS-2,Participants' homes in the City of Nottingham.,fulltext,Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?'",fulltext,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?'",100.0
696,PRECIS-2,Candidates were excluded from the study if active disease was identified at baseline per clinical ( presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,fulltext,Candidates were excluded from the study if active disease was identified at baseline per clinical ( presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,100.0
696,PRECIS-2,"Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",fulltext,"Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, 19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",100.0
696,PRECIS-2,Safety parameters evaluated as primary outcomes were defined as: (1) MRI parameters quantified by lesion activity analyses and changes in lesion volume (LV) and (2) clinical parameters that included the number of clinical relapses during the cessation period compared to the number of relapses before cessation in both the group as a whole as well as between the two randomised groups.,fulltext,Safety parameters evaluated as primary outcomes were defined as: (1) MRI parameters quantified by lesion activity analyses and changes in lesion volume (LV) and (2) clinical parameters that included the number of clinical relapses during the cessation period compared to the number of relapses before cessation in both the group as a whole as well as between the two randomised groups.,100.0
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",100.0
696,PRECIS-2,696.pdf,prompt,015.pdf,57.14285714285714
697,PRECIS-2,697.pdf,prompt,015.pdf,57.14285714285714
697,PRECIS-2,The group program was conducted at a local community center and included four to six participants per class.,fulltext,The group program was conducted at a local community center and included four to six participants per class.,100.0
697,PRECIS-2,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",fulltext,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",100.0
697,PRECIS-2,Assessments were conducted by physiotherapists blinded to group allocation and trained in administering the outcome measures.,fulltext,Assessments were conducted by physiotherapists blinded to group allocation and trained in administering the outcome measures.,100.0
697,PRECIS-2,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",fulltext,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",100.0
697,PRECIS-2,"Inclusion criteria: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",72.0
697,PRECIS-2,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",fulltext,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",100.0
697,PRECIS-2,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",fulltext,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",100.0
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle.,fulltext, Data were analyzed according to the intention-totreat principle,96.92307692307692
697,PRECIS-2,"In both group and home exercise sessions, participants completed eight, 6 minute exercises/stations per session plus a 5-minute warm up and cool down.",fulltext,"In both group and home exercise sessions, participants completed eight, 6 minute exercises/stations per session plus a 5-minute warm up and cool down.",100.0
697,PRECIS-2,"Outcome assessments were conducted at baseline, immediately post-intervention and at 8-week follow-up.",fulltext,"Outcome assessments were conducted at baseline, immediately postintervention and at 8-week follow-up.",99.01960784313727
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
705,PRECIS-2,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",99.33774834437085
705,PRECIS-2,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
705,PRECIS-2,"In usual care, health professionals encourage patients to take medication or follow therapy as best they can, and such encouragement would not count against a pragmatic design; if it also happens in usual care, allowing it in the trial is a pragmatic design decision.",prompt,"In usual care, health professionals encourage patients to take medication or follow therapy as best they can, and such encouragement would not count against a pragmatic design; if it also happens in usual care, allowing it in the trial is a pragmatic design decision.",100.0
705,PRECIS-2,Our planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext, planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,98.17073170731707
705,PRECIS-2,"Age and BMI restrictions reflect evidence suggesting the following: 1) overweight/obese men in their mid-30s may experience an attitudinal shift in relation to their health, increasing their receptiveness to change health behaviors, and 2) men who are obese or at risk for becoming obese are more likely to want to lose weight (16).",fulltext,"Age and BMI restrictions reflect evidence suggesting the following: 1) overweight/obese men in their mid-30s may experience an attitudinal shift in relation to their health, increasing their receptiveness to change health behaviors, and HOCKEY FANS IN TRAINING Medicine & Science in Sports & Exercise d 2507 APPLIED SCIENCES Downloaded from http://journals.lww.com/acsm-msse by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCyw CX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 07/17/2023 2) men who are obese or at risk for becoming obese are more likely to want to lose weight (16).",100.0
705,PRECIS-2,"Eligible participants were male 35–65 yr old with a BMI of ≥28 kg/m2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",99.09502262443439
705,PRECIS-2,A highly pragmatic design approach would allow for full flexibility in how end user recipients engage with the intervention.,prompt,A highly pragmatic design approach would allow for full flexibility in how end user recipients engage with the intervention.,100.0
705,PRECIS-2,"Details were provided in the protocol, but coaches were able to adapt delivery based on participants' needs and engagement.",fulltext,entives were also provided as part of the program to encourage program attendance and engagement ,51.21951219512195
705,PRECIS-2,"The remaining men were recruited through traditional media sources (14%), posters and handouts (9%), and other methods (1%).",fulltext,"The remaining men were recruited through traditional media sources (14%), posters and handouts (9%), and other methods (1%).",100.0
705,PRECIS-2,"Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",fulltext,"Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) included clinical outcomes (e.g., weight) and self-reported physical activity, diet, and self-rated health.",100.0
705,PRECIS-2,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",100.0
705,PRECIS-2,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",fulltext,"Across both sites, the most successful methods of recruitment included communication from the hockey team via e-mail or social media (e.g., Twitter) and word of mouth, where 40% and 36% of men were recruited, respectively.",100.0
705,PRECIS-2,Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only).,fulltext,Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only ,98.78048780487805
705,PRECIS-2,"The model included terms for time (0, 12 wk), group (intervention, comparator)–time, age, and site (London, Sarnia).",fulltext,"The model included terms for time (0, 12 wk), group (intervention, comparator)–time, age, and site (London, Sarnia).",100.0
705,PRECIS-2,705.pdf,prompt,015.pdf,85.71428571428572
705,PRECIS-2,Hockey FIT coaches (coach to participant ratio 2:20) from the central research team (see Gill et al. [14] for information on coach background and training).,fulltext,Hockey FIT coaches (coach to participant ratio 2:20) from the central research team (see Gill et al. [14] for information on coach background and training).,100.0
712,PRECIS-2,VAS was used to evaluate the pain,fulltext,VAS was used to evaluate the pain,100.0
712,PRECIS-2,"Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",fulltext,"Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",100.0
712,PRECIS-2,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups,fulltext,The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups,100.0
712,PRECIS-2,"Inclusion criteria - Pregnant women at their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",fulltext,"cted 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",87.41258741258741
712,PRECIS-2,The researcher that was responsible for applying the acupressure went through 32 hours’ worth of training.,fulltext,The researcher that was responsible for applying the acupressure went through 32 hours’ worth of training.,100.0
712,PRECIS-2,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain (Table 3).,fulltext,VAS was used to evaluate the pain and for predeveloped questions. The women were able to classify their perception of the pain (Table 3).,99.27536231884058
712,PRECIS-2,"Exclusions - severe preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",fulltext,"excluded: serious preeclampsia, placenta previa, immediate indication of cesarean, dilations at ≥ 8 cm and those that used analgesics for less than six hours from the study admission time.",95.26315789473684
712,PRECIS-2,712.pdf,prompt,015.pdf,71.42857142857143
713,PRECIS-2,"One to two weeks later the patient was contacted by phone. In the phone call, possibilities for participation were explored. An appointment at the research centre was set up for those who accepted the invitation.",fulltext,"One to two weeks later the patient was contacted by phone. In the phone call, possibilities for participation were explored. An appointment at the research centre was set up for those who accepted the invitation.",100.0
713,PRECIS-2,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.,fulltext,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease.,100.0
713,PRECIS-2,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
713,PRECIS-2,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV1 after inhalation of 200 μg albuterol in the post-bronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",fulltext,"Excluded were individuals who had another major disease (among them individuals with asthma who had more than 200 ml or 12% increase in FEV 1 after inhalation of 200 lg albuterol in the postbronchodilator spirometry), who were non-Icelandic speaking, not capable of travelling to the treatment site and those who had participated in a structured rehabilitation programme for people with COPD 6 months prior to the screening.",99.52830188679245
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,"An invitation letter signed by the patient’s physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",fulltext,"An invitation letter signed by the patient’s physician was sent to potential participants explaining that the study was a clinical, family trial and that as a client of the physician, the person had been identified as a possible participant and that in addition, participation by a close family member was requested.",100.0
713,PRECIS-2,The partnership approach is to work with patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,fulltext,The main approach is to work with patients and families to find out what is meaningful for them in life as regards health and jointly decide on that which is possible and relevant for each patient and family.,95.81395348837209
713,PRECIS-2,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,fulltext,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,100.0
714,PRECIS-2,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner’s request) for major social or medical reasons.",fulltext,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner’s request) for major social or medical reasons.",100.0
714,PRECIS-2,Patients randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month. Nurses were told to make up to four attempts to contact the patient by phone.,fulltext,Patients randomised to the telephone review group were sent a letter from their practice informing them that they had been allocated to receive a telephone review and that they should expect a call from the asthma nurse within a month. Nurses were told to make up to four attempts to contact the patient by phone.,100.0
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,100.0
714,PRECIS-2,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,fulltext,Follow up questionnaires on morbidity and satisfaction with the consultation were sent to the patients at three months.,100.0
714,PRECIS-2,Patients randomised to the face to face consultation arm were sent a written invitation to make an appointment to see the asthma nurse within a month.,fulltext,Patients randomised to the face to face consultation arm were sent a written invitation to make an appointment to see the asthma nurse within a month.,100.0
714,PRECIS-2,Four general practices in England.,fulltext,Four general practices in England.,100.0
714,PRECIS-2,We wrote to all eligible patients inviting them to take part in the study.,fulltext,We wrote to all eligible patients inviting them to take part in the study.,100.0
714,PRECIS-2,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,fulltext,All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care.,100.0
714,PRECIS-2,We gave the nurses standardised training in the study procedure.,fulltext,We gave the nurses standardised training in the study procedure.,100.0
714,PRECIS-2,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previDepartment,67.36401673640167
714,PRECIS-2,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
715,PRECIS-2,Both practitioners saw patients according to the protocol and any extra visits or admissions were recorded.,fulltext,Both practitioners saw patients according to the protocol and any extra visits or admissions were recorded.,100.0
715,PRECIS-2,Independent assessors were health professionals trained to perform joint counts and calculating the DAS28.,fulltext,Independent assessors were health professionals trained to perform joint counts and calculating the DAS28.,100.0
715,PRECIS-2,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",100.0
715,PRECIS-2,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness. The patients were then given questionnaires in ‘freepost’ return envelopes before consultation with their allocated practitioner.",fulltext,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness. The patients were then given questionnaires in ‘freepost’ return envelopes before consultation with their allocated practitioner.",100.0
715,PRECIS-2,"Patients ≥ 3 with acute respiratory tract infections. Exclusions not common cold but severe respiratory tract infections, peptic ulcer and asthma. But even asthma patients who were not sensitive to ibuprofen or aspirin eligible. Pregnant or breast feeding women are discouraged from taking ibuprofen when pregnant but can take as low a dose as possible of Paracetemol but as both being tested in the trial cannot include this group as participants. If include visually impaired increase organisation of trial (as in carers have to assist diary completion) but that would be norm and usual if prescribed ibuprofen or Paracetemol or steam treatment in usual care, so just easier for trialists to exclude. Small proportion of participants – so why exclude? Depressed and people with psychosis unreliable diary fillers, concerned with other things.",prompt,"Patients ≥ 3 with acute respiratory tract infections. Exclusions not common cold but severe respiratory tract infections, peptic ulcer and asthma. But even asthma patients who were not sensitive to ibuprofen or aspirin eligible. Pregnant or breast feeding women are discouraged from taking ibuprofen when pregnant but can take as low a dose as possible of Paracetemol but as both being tested in the trial cannot include this group as participants. If include visually impaired increase organisation of trial (as in carers have to assist diary completion) but that would be norm and usual if prescribed ibuprofen or Paracetemol or steam treatment in usual care, so just easier for trialists to exclude. Small proportion of participants – so why exclude? Depressed and people with psychosis unreliable diary fillers, concerned with other things.",100.0
715,PRECIS-2,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",100.0
715,PRECIS-2,Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,fulltext,Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",100.0
715,PRECIS-2,"NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",fulltext,"NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",100.0
715,PRECIS-2,The usual RLC is similar to the above except that it usually involves an allocated 15-min time slot.,fulltext,The usual RLC is similar to the above except that it usually involves an allocated 15-min time slot.,100.0
715,PRECIS-2,This study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,97.72727272727273
722,PRECIS-2,were eligible.,fulltext,were eligible.,100.0
722,PRECIS-2,"Each participant had to have, in their doctor’s view, indications for all and no contraindications to any component of at least one of two polypills",fulltext,"Each participant had to have, in their doctor’s view, indications for all and no contraindications to any component of at least one of two polypills",100.0
722,PRECIS-2,"This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to designated local pharmacies where all drugs (including the polypill) were dispensed.",fulltext,"This mostly involved doctors providing patients with written prescriptions, and patients presenting the prescriptions to Patel et al. 921 Downloaded from https://academic.oup.com/eurjpc/article/22/7/920/5927084 by Inactive user on 17 July 2023 designated local pharmacies where all drugs (including the polypill) were dispensed.",100.0
722,PRECIS-2,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",fulltext,"Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",100.0
722,PRECIS-2,All participants were treated by their regular doctor following randomization.,fulltext,All participants were treated by their regular doctor following randomization.,100.0
722,PRECIS-2,Prescription and dispensing of the polypill occurred in the same way as for other medications.,fulltext,Prescription and dispensing of the polypill occurred in the same way as for other medications.,100.0
722,PRECIS-2,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",fulltext,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",100.0
722,PRECIS-2,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",fulltext,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",100.0
722,PRECIS-2,high risk,prompt,high risk,100.0
722,PRECIS-2,722.pdf,prompt,015.pdf,57.14285714285714
722,PRECIS-2,"Central, computer-based randomization to polypill-based strategy or usual care was stratified by primary healthcare centre, type of indication (established CVD versus high risk), Indigenous identification and level of preventive treatment at baseline.",fulltext,"Central, computer-based randomization to polypillbased strategy or usual care was stratified by primary healthcare centre, type of indication (established CVD versus high risk), Indigenous identification and level of preventive treatment at baseline.",99.60159362549801
722,PRECIS-2,Patients ≥ 18 years of age with established CVD or an estimated five-year CVD risk of ≥15%,fulltext, established CVD or an estimated five-year CVD risk of 15%,65.55555555555556
722,PRECIS-2,"We conducted a randomized, open-label trial involving 623 participants from Australian general practices.",fulltext,"We conducted a randomized, open-label trial involving 623 participants from Australian general practices.",100.0
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",100.0
722,PRECIS-2,Rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.,fulltext,Rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.,100.0
725,PRECIS-2,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck. The degree of displacement had to be sufficient for the treating surgeon to consider surgical intervention but did not have to meet the displacement criteria of Neer for inclusion in the trial.,fulltext,"Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck. The degree of displacement had to be sufficient for the treating surgeon to consider surgical intervention but did not have to meet the displacement criteria of Neer 10 (1 cm or 45° angulation of displaced parts, or both) for inclusion in the trial.",100.0
725,PRECIS-2,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",fulltext,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",100.0
725,PRECIS-2,"Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.",fulltext,"Consistent with the study protocol, 29 of 32 recruiting centers (91%) recommended 3 or more weeks of sling use.",100.0
725,PRECIS-2,Follow-up was up to 2 years (until April 2013) for all patients.,fulltext,Follow-up was up to 2 years (until April 2013) for all patients.,100.0
725,PRECIS-2,"Care pathways for all patients included outpatient- and community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",fulltext,"Care pathways for all patients included outpatientand community-based rehabilitation, which primarily comprised 1 or more 1-on-1 sessions with a physiotherapist that focused on restoring function.",98.98989898989899
725,PRECIS-2,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",fulltext,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",100.0
725,PRECIS-2,"Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",fulltext,"Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",100.0
725,PRECIS-2,"The OSS was collected by postal questionnaires at 6, 12, and 24 months. There was no trial-related clinical assessment or radiological follow-up of patients.",fulltext,"The OSS was collected by postal questionnaires at 6, 12, and 24 months. There was no trial-related clinical assessment or radiological follow-up of patients.",100.0
725,PRECIS-2,Patients received their allocated treatment from the recruiting hospital.,fulltext,Patients received their allocated treatment from the recruiting hospital.,100.0
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",100.0
725,PRECIS-2,"Of 563 eligible patients, 250 (44%) consented to take part in the trial.",fulltext,"he 563 eligible patients, 250 (44%) consented to take part in the tria",94.44444444444444
733,PRECIS-2,"A three-arm, parallel-design cluster controlled trial was used, with allocation at the level of general practice in two centres (London and Nottingham/Derby).",fulltext,"A three-arm, parallel-design cluster controlled trial was used, with allocation at the level of general practice in two centres (London and Nottingham/Derby).",100.0
733,PRECIS-2,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.,fulltext,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.,100.0
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",100.0
733,PRECIS-2,"The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",100.0
733,PRECIS-2,There was no evidence of difference in primary outcome between adherers and non-adherers for either analysis.,fulltext,There was no evidence of difference in primary outcome between adherers and non-adherers for either analysis.,100.0
733,PRECIS-2,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly.",100.0
733,PRECIS-2,The primary outcome was the proportion reaching the recommended physical activity target 12 months post-intervention.,fulltext,The primary outcome was the proportion reaching the recommended physical activity target 12 months post-intervention.,100.0
733,PRECIS-2,and not all participants in the OEP arm received per protocol peer mentor support.,fulltext,and not all participants in the OEP arm received per protocol peer mentor support.,100.0
733,PRECIS-2,Patients were excluded if they: had experienced ≥3 falls in the previous year; had unstable clinical conditions; would be unable to follow instructions about exercise safely; or were receiving palliative care.,fulltext,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,100.0
733,PRECIS-2,All FaME classes were fully staffed but recruitment of peer mentors was difficult,fulltext,All FaME classes were fully staffed but recruitment of peer mentors was difficult,100.0
733,PRECIS-2,"Physical activity was assessed using three validated questionnaires: Phone-FITT, the Physical Activity Scale for the Elderly (PASE), and the Community Healthy Activities Model Program for Seniors (CHAMPS).",fulltext,"Physical activity was assessed using three validated questionnaires: Phone-FITT, the Physical Activity Scale for the Elderly (PASE), and the Community Healthy Activities Model Program for Seniors (CHAMPS).",100.0
733,PRECIS-2,Patients were eligible to participate if they were: community dwelling aged ≥65 years; independently mobile (with or without a walking aid); and physically able to take part in group exercise.,fulltext,Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,100.0
733,PRECIS-2,The primary analysis was carried out on 572 participants with complete data on CHAMPS score at baseline and 12months follow-up. Also carried out were two multiple imputation analyses,fulltext,The primary analysis was carried out on 572 participants with complete data on CHAMPS score at baseline and 12months follow-up. Also carried out were two multiple imputation analyses,100.0
733,PRECIS-2,The primary time point was chosen as 12 months post-intervention to match other trials.,fulltext,The primary time point was chosen as 12 months postintervention to match other trials.,98.85057471264368
733,PRECIS-2,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",100.0
